KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares RepurchasedShort-Term Debt issuances
Ratios

Abbott Laboratories (ABT) Shares Issued (2016 - 2025)

Historic Shares Issued for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $69.0 million.

  • Abbott Laboratories' Shares Issued fell 2500.0% to $69.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $416.0 million, marking a year-over-year increase of 5238.1%. This contributed to the annual value of $264.0 million for FY2024, which is 5808.38% up from last year.
  • Latest data reveals that Abbott Laboratories reported Shares Issued of $69.0 million as of Q3 2025, which was down 2500.0% from $35.0 million recorded in Q2 2025.
  • Abbott Laboratories' Shares Issued's 5-year high stood at $287.0 million during Q1 2025, with a 5-year trough of $10.0 million in Q2 2022.
  • Its 5-year average for Shares Issued is $65.5 million, with a median of $57.0 million in 2022.
  • Within the past 5 years, the most significant YoY rise in Abbott Laboratories' Shares Issued was 41250.0% (2021), while the steepest drop was 7017.54% (2021).
  • Quarter analysis of 5 years shows Abbott Laboratories' Shares Issued stood at $82.0 million in 2021, then tumbled by 50.0% to $41.0 million in 2022, then decreased by 17.07% to $34.0 million in 2023, then fell by 26.47% to $25.0 million in 2024, then surged by 176.0% to $69.0 million in 2025.
  • Its Shares Issued was $69.0 million in Q3 2025, compared to $35.0 million in Q2 2025 and $287.0 million in Q1 2025.